{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T09:57:08Z","timestamp":1755597428710,"version":"3.40.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Pneumonia is a common disease-causing hospitalization. When a healthcare-associated infection is suspected, antibiotics that provide coverage for multi-drug resistant (MDR) or extended-spectrum beta-lactamase (ESBL) bacteria are frequently prescribed. Limited data is available for guidance on using meropenem as a first-line empiric antimicrobial in hospitalized patients with risk factors for MDR\/ESBL bacterial infections.<\/jats:p>\n            <jats:p>This was a single-center, retrospective study designed and conducted to identify factors associated with positive cultures for MDR\/ESBL pathogens in hospitalized patients with suspected healthcare-associated pneumonia.<\/jats:p>\n            <jats:p>Of the 246 patients, 103 patients (41%) received meropenem. Among patients prescribed meropenem, MDR\/ESBL pathogens were detected in only 20 patients (13%). Patients admitted from a skilled nursing facility\/long-term acute care (SNF\/LTAC) or with a history of a positive culture for MDR\/ESBL pathogens were significantly associated with positive cultures of MDR\/ESBL pathogens during the hospitalization (odds ratio [95% confidence intervals], 31.40 [5.20\u2013189.6] in SNF\/LTAC and 18.50 [2.98\u2013115.1] in history of culture-positive MDR\/ESBL pathogen). There was no significant difference in mortality between the 3 antibiotic groups.<\/jats:p>\n            <jats:p>Admission from a SNF\/LTAC or having a history of cultures positive for MDR\/ESBL pathogens were significantly associated with a positive culture for MDR\/ESBL pathogens during the subsequent admission. We did not detect significant association between meropenem use as a first-line drug and morbidity and mortality for patients admitted to the hospital with suspected healthcare-associated pneumonia, and further prospective studies with larger sample size are needed to confirm our findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027488","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T13:39:24Z","timestamp":1633700364000},"page":"e27488","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Factors associated with the appropriate use of ultra-broad spectrum antibiotics, meropenem, for suspected healthcare-associated pneumonia"],"prefix":"10.1097","volume":"100","author":[{"given":"Nathan","family":"Kirsch","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Nevada, Las Vegas, NV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Ha","sequence":"additional","affiliation":[{"name":"Department of Medicine, Korea University College of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Taik","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea"},{"name":"Department of Family Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Frisch","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University Medical Center, Las Vegas, NV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Won","family":"Yoo","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Internal Medicine, University of Nevada, Las Vegas, NV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Grossman","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Nevada, Las Vegas, NV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neema","family":"Oroomchi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Nevada, Las Vegas, NV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenobu","family":"Shigemitsu","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, Tokyo Medical Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad L.","family":"Cross","sequence":"additional","affiliation":[{"name":"Department of Environmental and Occupational Health, University of Nevada, Las Vegas, NV."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7320-9302","authenticated-orcid":false,"given":"Mutsumi John","family":"Kioka","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Nevada, Las Vegas, NV"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(18)30060-4","article-title":"WHO global antimicrobial resistance surveillance system early implementation 2016\u201317","volume":"18","author":"Tornimbene","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R2-20250504","first-page":"938","article-title":"Antibiotic resistance threats in the United States: stepping back from the brink","volume":"89","author":"Solomon","year":"2014","journal-title":"Am Fam Physician"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cid\/ciw323","article-title":"Antibiotic Stewardship Programs in U.S. acute care hospitals: findings from the 2014 national healthcare safety network annual hospital survey","volume":"63","author":"Pollack","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R5-20250504","first-page":"194","article-title":"Vital signs: improving antibiotic use among hospitalized patients","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cmi.2015.12.002","article-title":"The negative impact of antibiotic resistance","volume":"22","author":"Friedman","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"(Suppl 4)","key":"R7-20250504","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/cc6821","article-title":"The role of carbapenems in initial therapy for serious Gram-negative infections","volume":"12","author":"Rahal","year":"2008","journal-title":"Crit Care"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1017\/ice.2015.136","article-title":"Factors influencing antibiotic-prescribing decisions among inpatient physicians: a qualitative investigation","volume":"36","author":"Livorsi","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R9-20250504","first-page":"63","article-title":"A study of antibiotic prescription pattern in patients referred to tertiary care center in Northern India","volume":"5","author":"Kaur","year":"2018","journal-title":"Ther Adv Infect Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jac\/dkx363","article-title":"Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland infection intelligence platform","volume":"73","author":"Malcolm","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cir840","article-title":"Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia","volume":"54","author":"Aliberti","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/CCM.0b013e31819ded31","article-title":"Prospective validation of the intensive care unit admission Mortality Probability Model (MPM0-III)","volume":"37","author":"Higgins","year":"2009","journal-title":"Crit Care Med"},{"key":"R15-20250504","first-page":"767","article-title":"Recommendations from the 2016 guidelines for the management of adults with hospital-acquired or ventilator-associated pneumonia","volume":"42","author":"Kumar","year":"2017","journal-title":"P T"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00134-014-3239-2","article-title":"Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study","volume":"40","author":"Valles","year":"2014","journal-title":"Intensive Care Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.111.3.676","article-title":"Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia","volume":"111","author":"Luna","year":"1997","journal-title":"Chest"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archinternmed.2007.84","article-title":"Antibiotic timing and errors in diagnosing pneumonia","volume":"168","author":"Welker","year":"2008","journal-title":"Arch Intern Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4103\/0975-7406.90108","article-title":"Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India","volume":"3","author":"Williams","year":"2011","journal-title":"J Pharm Bioallied Sci"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1186\/1364-8535-17-1001","article-title":"Unrevealing culture-negative severe sepsis","volume":"17","author":"de Prost","year":"2013","journal-title":"Crit Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:34:38Z","timestamp":1746340478000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":21,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027488","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"assertion":[{"value":"2020-09-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}